Drug Reverses Age-Related Vision Loss

Life Biosciences is testing a groundbreaking drug, ER-100, designed to reverse age-related vision loss in humans—after proving success in monkeys. Targeting glaucoma and NAION by rewinding cellular aging in optic nerve cells, this is the first FDA-approved human trial for cellular rejuvenation therapy. If it works, it could revolutionize how we treat age-related diseases—and maybe even extend healthy human lifespan.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/3f1ab4eb7ba87377